These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 981707)

  • 1. Metabolism of PG in man: effect of furosemide on the excretion of the main metabolite of PG F2alpha.
    Abe K; Otsuka Y; Yasujima M; Ciba S; Seino M; Irokawa N; Yoshinaga K
    Prostaglandins; 1976 Nov; 12(5):843-8. PubMed ID: 981707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of 5beta,7alpha-dihydroxy-11-oxotetranor-prostane-1,16-dioic acid as a urinary metabolite of prostaglandin F2alpha in the rat.
    Brash AR; Baillie TA
    Biochim Biophys Acta; 1979 Feb; 572(2):371-5. PubMed ID: 427184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of 8-methoxypsoralen plus UV-A (PUVA) on the excretion of the main urinary metabolite of prostaglandins F 1 alpha and F 2 alpha in patients with psoriasis.
    Briffa DV; Greaves MW; Hensby CN
    Clin Exp Dermatol; 1981 Sep; 6(5):471-6. PubMed ID: 7318237
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of main urinary metabolite of PGFs in chronic lung diseases.
    Murao M; Uchiyama K; Takahashi W; Hirata F; Inagawa T
    Adv Prostaglandin Thromboxane Res; 1980; 7():965-8. PubMed ID: 7369061
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension.
    Abe K; Yasujima M; Chiba S; Irokawa N; Ito T; Yoshinaga K; Saito T
    Prostaglandins; 1977 Sep; 14(3):513-21. PubMed ID: 905575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced excretion of the main urinary metabolite of prostaglandin F1 alpha and F2 alpha in psoriatic patients.
    Katayama H; Kawada A; Endoh C; Hori H; Yoshikawa K
    Acta Derm Venereol; 1983; 63(3):233-5. PubMed ID: 6192638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of furosemide on renal prostaglandins E2 and F2 alpha in normal subjects and in patients with essential hypertension.
    Rathaus M; Bauminger S; Bernheim J
    Isr J Med Sci; 1980 Feb; 16(2):106-10. PubMed ID: 7364563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
    Brater DC; Beck JM; Adams BV; Campbell WB
    Eur J Pharmacol; 1980 Jul; 65(2-3):213-9. PubMed ID: 7398787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of ultraviolet B irradiation on the excretion of the main urinary metabolite of prostaglandin F1 alpha and F2 alpha in psoriatic and normal subjects.
    Katayama H; Hori H
    Acta Derm Venereol; 1984; 64(1):1-4. PubMed ID: 6203274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in urinary prostaglandin excretion in hypertension patients undergoing variants of furosemide administration].
    Dzhusipov AK; Nekrasova AA
    Ter Arkh; 1984; 56(4):90-4. PubMed ID: 6587605
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the renal prostaglandins in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):25-8. PubMed ID: 6587654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.
    Rathaus M; Bernheim J
    Isr J Med Sci; 1982 Feb; 18(2):231-4. PubMed ID: 6950926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of main urinary metabolite of prostaglandin F2alpha in patients with diffuse interstitial fibrosing pneumonitis (DIFP) and other respiratory diseases.
    Kitamura S; Ishihara Y; Kosaka K
    Tohoku J Exp Med; 1979 Feb; 127(2):177-81. PubMed ID: 760264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased urinary protein excretion after intravenous injection of furosemide in man.
    Ylitalo P; Pasternack A; Kallio S; Vänttinen T; Metsä-Ketelä T
    Acta Med Scand; 1980; 208(4):279-83. PubMed ID: 7004092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of furosemide on urinary excretion of prostaglandin E2 and F2 alpha in rabbits.
    Oliw E; Anggård E
    Acta Physiol Scand; 1979 Mar; 105(3):367-73. PubMed ID: 443065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin formation in man during intake of different amounts of linoleic acid in formula diets.
    Adam O; Wolfram G; Zöllner N
    Ann Nutr Metab; 1982; 26(5):315-23. PubMed ID: 7137955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
    Halushka PV; Margolius HS; Allen H; Conradi EC
    Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin (PG) analysis in urine of humans and rats by different radioimmunoassays: effect on PG-excretion by PG-synthetase inhibitors, laparotomy and furosemide.
    Scherer B; Schnermann J; Sofroniev M; Weber PC
    Prostaglandins; 1978 Feb; 15(2):255-66. PubMed ID: 416466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deuterium- and tritium-labeled (+/-)-7alpha-hydroxy-5,11-diketotetranorprostane-1,16-dioic acid.
    Rosegay A; Taub D
    Prostaglandins; 1976 Nov; 12(5):785-7. PubMed ID: 981702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.